FIXX Annual EBIT
-$92.10 M
+$41.18 M+30.90%
01 December 2023
Summary:
As of January 21, 2025, FIXX annual earnings before interest & taxes is -$92.10 million, with the most recent change of +$41.18 million (+30.90%) on December 1, 2023. During the last 3 years, it has risen by +$38.16 million (+29.30%).FIXX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX Quarterly EBIT
-$9.41 M
+$14.95 M+61.36%
01 December 2023
Summary:
As of January 21, 2025, FIXX quarterly earnings before interest & taxes is -$9.41 million, with the most recent change of +$14.95 million (+61.36%) on December 1, 2023. Over the past year, it has increased by +$14.95 million (+61.36%).FIXX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX TTM EBIT
-$92.10 M
+$25.08 M+21.40%
01 December 2023
Summary:
As of January 21, 2025, FIXX TTM earnings before interest & taxes is -$92.10 million, with the most recent change of +$25.08 million (+21.40%) on December 1, 2023. Over the past year, it has increased by +$25.08 million (+21.40%).FIXX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FIXX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.9% | +61.4% | +21.4% |
| 3 y3 years | +29.3% | +61.4% | +21.4% |
| 5 y5 years | -53.7% | +61.4% | +21.4% |
FIXX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +843.6% | +747.3% | +1863.2% |
Homology Medicines EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$92.10 M(-30.9%) | -$9.41 M(-61.4%) | -$92.10 M(-21.4%) |
| Sept 2023 | - | -$24.36 M(-20.9%) | -$117.18 M(-6.8%) |
| June 2023 | - | -$30.82 M(+12.0%) | -$125.68 M(+2.0%) |
| Mar 2023 | - | -$27.51 M(-20.2%) | -$123.17 M(-7.6%) |
| Dec 2022 | -$133.28 M(+38.9%) | -$34.49 M(+5.0%) | -$133.28 M(+0.7%) |
| Sept 2022 | - | -$32.86 M(+16.1%) | -$132.41 M(+1.7%) |
| June 2022 | - | -$28.31 M(-24.8%) | -$130.21 M(-1.7%) |
| Mar 2022 | - | -$37.62 M(+11.9%) | -$132.46 M(+38.0%) |
| Dec 2021 | -$95.95 M(-26.3%) | -$33.63 M(+9.7%) | -$95.95 M(+4.1%) |
| Sept 2021 | - | -$30.66 M(+0.4%) | -$92.13 M(+2.7%) |
| June 2021 | - | -$30.55 M(+2650.0%) | -$89.74 M(-5.4%) |
| Mar 2021 | - | -$1.11 M(-96.3%) | -$94.88 M(-27.2%) |
| Dec 2020 | -$130.26 M | -$29.80 M(+5.4%) | -$130.26 M(+3.4%) |
| Sept 2020 | - | -$28.27 M(-20.8%) | -$126.02 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$35.70 M(-2.2%) | -$129.04 M(+6.4%) |
| Mar 2020 | - | -$36.49 M(+42.8%) | -$121.31 M(+10.3%) |
| Dec 2019 | -$109.94 M(+83.5%) | -$25.56 M(-18.3%) | -$109.94 M(+5.2%) |
| Sept 2019 | - | -$31.29 M(+11.9%) | -$104.56 M(+17.6%) |
| June 2019 | - | -$27.97 M(+11.3%) | -$88.90 M(+19.6%) |
| Mar 2019 | - | -$25.12 M(+24.5%) | -$74.35 M(+24.1%) |
| Dec 2018 | -$59.93 M(+102.1%) | -$20.17 M(+29.0%) | -$59.92 M(+15.2%) |
| Sept 2018 | - | -$15.63 M(+16.5%) | -$52.02 M(+20.8%) |
| June 2018 | - | -$13.42 M(+25.5%) | -$43.05 M(+20.7%) |
| Mar 2018 | - | -$10.70 M(-12.8%) | -$35.66 M(+20.2%) |
| Dec 2017 | -$29.66 M(+196.6%) | -$12.26 M(+84.0%) | -$29.66 M(+70.5%) |
| Sept 2017 | - | -$6.66 M(+10.4%) | -$17.39 M(+62.1%) |
| June 2017 | - | -$6.04 M(+28.7%) | -$10.73 M(+128.7%) |
| Mar 2017 | - | -$4.69 M | -$4.69 M |
| Dec 2016 | -$10.00 M | - | - |
FAQ
- What is Homology Medicines annual earnings before interest & taxes?
- What is the all time high annual EBIT for Homology Medicines?
- What is Homology Medicines annual EBIT year-on-year change?
- What is Homology Medicines quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Homology Medicines?
- What is Homology Medicines quarterly EBIT year-on-year change?
- What is Homology Medicines TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Homology Medicines?
- What is Homology Medicines TTM EBIT year-on-year change?
What is Homology Medicines annual earnings before interest & taxes?
The current annual EBIT of FIXX is -$92.10 M
What is the all time high annual EBIT for Homology Medicines?
Homology Medicines all-time high annual earnings before interest & taxes is -$9.76 M
What is Homology Medicines annual EBIT year-on-year change?
Over the past year, FIXX annual earnings before interest & taxes has changed by +$41.18 M (+30.90%)
What is Homology Medicines quarterly earnings before interest & taxes?
The current quarterly EBIT of FIXX is -$9.41 M
What is the all time high quarterly EBIT for Homology Medicines?
Homology Medicines all-time high quarterly earnings before interest & taxes is -$1.11 M
What is Homology Medicines quarterly EBIT year-on-year change?
Over the past year, FIXX quarterly earnings before interest & taxes has changed by +$14.95 M (+61.36%)
What is Homology Medicines TTM earnings before interest & taxes?
The current TTM EBIT of FIXX is -$92.10 M
What is the all time high TTM EBIT for Homology Medicines?
Homology Medicines all-time high TTM earnings before interest & taxes is -$4.69 M
What is Homology Medicines TTM EBIT year-on-year change?
Over the past year, FIXX TTM earnings before interest & taxes has changed by +$25.08 M (+21.40%)